Veracyte is a pioneering global diagnostics company. Our tests provide trustworthy and actionable ANSWERS that improve care throughout the patient journey.

We ask the right questions and provide answers that give physicians and patients a clearer path forward.

Our tests leverage innovations in genomic technology and machine learning to enable more confident diagnostic, prognostic and treatment decisions in challenging diseases such as lung cancer, prostate and bladder cancers, thyroid cancer, breast cancer and idiopathic pulmonary fibrosis. We are creating new standards of care by enabling more patients to avoid unnecessary procedures, speeding time to diagnosis and treatment, and removing costs from the healthcare system.

We are changing today's clinical practice standards. We are making a difference in the lives of physicians and patients.